When The Brain Stops Listening: Leptin Resistance As A Driver Of Hippocampal Dysfunction And Cognitive Impairment"- A Systematic Review
DOI:
https://doi.org/10.63682/jns.v14i8.8368Keywords:
leptin resistance, hippocampal plasticity, cognitive dysfunction, obesity-related memory loss, leptin sensitizersAbstract
Background:Leptin, a key adipocyte-derived hormone, is essential for maintaining energy homeostasis and also plays a significant neuromodulatory role, particularly within the hippocampus—a brain region critical for learning, memory, and executive function. In obesity and related metabolic disorders, persistent elevation of leptin levels often leads to leptin resistance, a condition marked by reduced sensitivity to leptin signalling. This resistance not only contributes to the progression of obesity but also adversely affects hippocampal function and cognitive performance.
Scope of the Review:This review explores the mechanistic links between hippocampal leptin resistance and the impairment of synaptic plasticity. Special focus is given to its detrimental effects on long-term potentiation (LTP) and long-term depression (LTD), two cellular processes fundamental to memory consolidation and learning.
Major Findings: Emerging evidence reveals that leptin resistance disrupts N-Methyl-D-aspartate (NMDA) receptor signalling and alters hippocampal architecture, resulting in impaired spatial memory and cognitive decline. High-fat diets (HFDs), a major contributor to leptin resistance, further compromise hippocampal synaptic function. Both animal and human studies underline the relevance of these mechanisms in the context of obesity-induced neurocognitive dysfunction.
Conclusions and Future Directions: Therapeutic strategies aimed at restoring leptin signalling, such as the use of leptin sensitizers (e.g., amylin analogs, Celastrol), show promise in alleviating cognitive impairments. Additionally, lifestyle modifications like caloric restriction and regular physical activity can enhance leptin sensitivity and promote synaptic health. This review highlights the potential of targeted interventions in mitigating obesity-associated cognitive decline through restoration of hippocampal leptin signalling.
Downloads
References
Drougard, A.; Fournel, A.; Valet, P.; Knauf, C. Impact of hypothalamic reactive oxygen species in the regulation of energy metabolism and food intake. Front. Neurosci. 2015, 9, 56. [Google Scholar] [CrossRef]
.Coccurello, R.; Maccarrone, M. Hedonic Eating and the “Delicious Circle”: From Lipid-Derived Mediators to Brain Dopamine and Back. Front. Neurosci. 2018, 12, 271. [Google Scholar] [CrossRef]
.Wiesner, G.; Vaz, M.; Collier, G.; Seals, D.; Kaye, D.; Jennings, G.; Lambert, G.; Wilkinson, D.; Esler, M. Leptin is released from the human brain: Influence of adiposity and gender. J. Clin. Endocrinol. Metab. 1999, 84, 2270–2274. [Google Scholar] [CrossRef]
. Ahima, R.S.; Flier, J.S. Leptin. Annu. Rev. Physiol. 2000, 62, 413–437. [Google Scholar] [CrossRef] [PubMed]
. Cinti, S. The adipose organ: Morphological perspectives of adipose tissues. Proc. Nutr. Soc. 2001, 60, 319–328. [Google Scholar] [CrossRef]
. Considine, R.V. Regulation of leptin production. Rev. Endocr. Metab. Disord. 2001, 2, 357–363. [Google Scholar] [CrossRef]
. Park, H.K.; Ahima, R.S. Physiology of leptin: Energy homeostasis, neuroendocrine function and metabolism. Metabolism 2015, 64, 24–34. [Google Scholar] [CrossRef] [PubMed]
. Ramos-Lobo, A.M.; Donato, J., Jr. The role of leptin in health and disease. Temperature 2017, 4, 258–291. [Google Scholar] [CrossRef] [PubMed]
. Caron, A.; Lee, S.; Elmquist, J.K.; Gautron, L. Leptin and brain-adipose crosstalks. Nat. Rev. Neurosci. 2018, 19, 153–165. [Google Scholar] [CrossRef] [PubMed]
Lynes, M.D.; Tseng, Y.H. Deciphering adipose tissue heterogeneity. Ann. N. Y. Acad. Sci. 2018, 1411, 5–20. [Google Scholar] [CrossRef] [PubMed]
Cinti, S. Adipose Organ Development and Remodeling. Compr. Physiol. 2018, 8, 1357–1431. [Google Scholar] [PubMed]
. Atkinson, L.L.; Fischer, M.A.; Lopaschuk, G.D. Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis. J. Biol. Chem. 2002, 277, 29424–29430. [Google Scholar] [CrossRef] [PubMed]
. Rajapurohitam, V.; Gan, X.T.; Kirshenbaum, L.A.; Karmazyn, M. The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ. Res. 2003, 93, 277–279. [Google Scholar] [CrossRef]
. Kanoski, S.E.; Hayes, M.R.; Greenwald, H.S.; Fortin, S.M.; Gianessi, C.A.; Gilbert, J.R.; Grill, H.J. Hippocampal leptin signaling reduces food intake and modulates food-related memory processing. Neuropsychopharmacology 2011, 36, 1859–1870. [Google Scholar] [CrossRef]
. Wayner, M.J.; Armstrong, D.L.; Phelix, C.F.; Oomura, Y. Orexin-A (Hypocretin-1) and leptin enhance LTP in the dentate gyrus of rats in vivo. Peptides 2004, 25, 991–996. [Google Scholar] [CrossRef]
. Farr, S.A.; Banks, W.A.; Morley, J.E. Effects of leptin on memory processing. Peptides 2006, 27, 1420–1425. [Google Scholar] [CrossRef]
. Oomura, Y.; Hori, N.; Shiraishi, T.; Fukunaga, K.; Takeda, H.; Tsuji, M.; Matsumiya, T.; Ishibashi, M.; Aou, S.; Li, X.L.; et al. Leptin facilitates learning and memory performance and enhances hippocampal CA1 long-term potentiation and CaMK II phosphorylation in rats. Peptides 2006, 27, 2738–2749. [Google Scholar] [CrossRef]
. O’Malley, D.; MacDonald, N.; Mizielinska, S.; Connolly, C.N.; Irving, A.J.; Harvey, J. Leptin promotes rapid dynamic changes in hippocampal dendritic morphology. Mol. Cell. Neurosci. 2007, 35, 559–572. [Google Scholar] [CrossRef] [PubMed]
. Shioda, S.; Funahashi, H.; Nakajo, S.; Yada, T.; Maruta, O.; Nakai, Y. Immunohistochemical localization of leptin receptor in the rat brain. Neurosci. Lett. 1998, 243, 41–44. [Google Scholar] [CrossRef]
. Muoio, D.M.; Lynis Dohm, G. Peripheral metabolic actions of leptin. Best Pract. Res. Clin. Endocrinol. Metab. 2002, 16, 653–666. [Google Scholar] [CrossRef]
. Huo, L.; Grill, H.J.; Bjørbaek, C. Divergent regulation of proopiomelanocortin neurons by leptin in the nucleus of the solitary tract and in the arcuate hypothalamic nucleus. Diabetes 2006, 55, 567–573. [Google Scholar] [CrossRef]
. Fulton, S.; Pissios, P.; Manchon, R.P.; Stiles, L.; Frank, L.; Pothos, E.N.; Maratos-Flier, E.; Flier, J.S. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 2006, 51, 811–822. [Google Scholar] [CrossRef]
. Walker, C.D.; Long, H.; Williams, S.; Richard, D. Long-lasting effects of elevated neonatal leptin on rat hippocampal function, synaptic proteins and NMDA receptor subunits. J. Neurosci. Res. 2007, 85, 816–828. [Google Scholar] [CrossRef]
. Bjørbaek, C. Central leptin receptor action and resistance in obesity. J. Investig. Med. 2009, 57, 789–794. [Google Scholar] [CrossRef]
. Casado, M.E.; Collado-Pérez, R.; Frago, L.M.; Barrios, V. Recent Advances in the Knowledge of the Mechanisms of Leptin Physiology and Actions in Neurological and Metabolic Pathologies. Int. J. Mol. Sci. 2023, 24, 1422. [Google Scholar] [CrossRef] [PubMed]
. Tartaglia, L.A.; Dembski, M.; Weng, X.; Deng, N.; Culpepper, J.; Devos, R.; Richards, G.J.; Campfield, L.A.; Clark, F.T.; Deeds, J.; et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995, 83, 1263–1271. [Google Scholar] [CrossRef] [PubMed]
Gorska, E.; Popko, K.; Stelmaszczyk-Emmel, A.; Ciepiela, O.; Kucharska, A.; Wasik, M. Leptin receptors. Eur. J. Med. Res. 2010, 15 (Suppl. S2), 50–54. [Google Scholar] [CrossRef]
. Obradovic, M.; Sudar-Milovanovic, E.; Soskic, S.; Essack, M.; Arya, S.; Stewart, A.J.; Gojobori, T.; Isenovic, E.R. Leptin and Obesity: Role and Clinical Implication. Front. Endocrinol. 2021, 12, 585887. [Google Scholar] [CrossRef]
Lindqvist, A.; Mohapel, P.; Bouter, B.; Frielingsdorf, H.; Pizzo, D.; Brundin, P.; Erlanson-Albertsson, C. High-fat diet impairs hippocampal neurogenesis in male rats. Eur. J. Neurol. 2006, 13, 1385–1388. [Google Scholar] [CrossRef]
. Erichsen, J.M.; Fadel, J.R.; Reagan, L.P. Peripheral versus central insulin and leptin resistance: Role in metabolic disorders, cognition, and neuropsychiatric diseases. Neuropharmacology 2022, 203, 108877. [Google Scholar] [CrossRef]
. Mota, B.; Brás, A.R.; Araújo-Andrade, L.; Silva, A.; Pereira, P.A.; Madeira, M.D.; Cardoso, A. High-Caloric Diets in Adolescence Impair Specific GABAergic Subpopulations, Neurogenesis, and Alter Astrocyte Morphology. Int. J. Mol. Sci. 2024, 25, 5524. [Google Scholar] [CrossRef]
. Del Olmo, N.; Ruiz-Gayo, M. Influence of High-Fat Diets Consumed During the Juvenile Period on Hippocampal Morphology and Function. Front. Cell. Neurosci. 2018, 12, 439. [Google Scholar] [CrossRef]
.Freeman, L.R.; Haley-Zitlin, V.; Rosenberger, D.S.; Granholm, A.C. Damaging effects of a high-fat diet to the brain and cognition: A review of proposed mechanisms. Nutr. Neurosci. 2014, 17, 241–251. [Google Scholar] [CrossRef]
Pantiya, P.; Thonusin, C.; Chunchai, T.; Ongnok, B.; Nawara, W.; Arunsak, B.; Chattipakorn, N.; Chattipakorn, S.C. Higher untrained fitness exerts a neuroprotection in Independence to caloric restriction or exercise in high-fat diet-induced obesity. Exp. Neurol. 2023, 365, 114416. [Google Scholar] [CrossRef] [PubMed]
Paulo, S.L.; Miranda-Lourenço, C.; Belo, R.F.; Rodrigues, R.S.; Fonseca-Gomes, J.; Tanqueiro, S.R.; Geraldes, V.; Rocha, I.; Sebastião, A.M.; Xapelli, S.; et al. High Caloric Diet Induces Memory Impairment and Disrupts Synaptic Plasticity in Aged Rats. Curr. Issues Mol. Biol. 2021, 43, 2305–2319. [Google Scholar] [CrossRef] [PubMed]
. Akazawa, C.; Shigemoto, R.; Bessho, Y.; Nakanishi, S.; Mizuno, N. Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats. J. Comp. Neurol. 1994, 347, 150–160. [Google Scholar] [CrossRef] [PubMed]
. Monyer, H.; Burnashev, N.; Laurie, D.J.; Sakmann, B.; Seeburg, P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994, 12, 529–540. [Google Scholar] [CrossRef] [PubMed]
. Law, A.J.; Weickert, C.S.; Webster, M.J.; Herman, M.M.; Kleinman, J.E.; Harrison, P.J. Changes in NMDA receptor subunit mRNAs and cyclophilin mRNA during development of the human hippocampus. Ann. N. Y. Acad. Sci. 2003, 1003, 426–430. [Google Scholar] [CrossRef]
Huang, X.T.; Yue, S.J.; Li, C.; Guo, J.; Huang, Y.H.; Han, J.Z.; Feng, D.D.; Luo, Z.Q. Antenatal blockade of N-methyl-D-aspartate receptors by Memantine reduces the susceptibility to diabetes induced by a high-fat diet in rats with intrauterine growth restriction. Biol. Reprod. 2017, 96, 960–970. [Google Scholar] [CrossRef] [PubMed]
. Hermanussen, M.; Tresguerres, J.A. A new anti-obesity drug treatment: First clinical evidence that, antagonising glutamate-gated Ca2+ ion channels with memantine normalises binge-eating disorders. Econ. Hum. Biol. 2005, 3, 329–337. [Google Scholar] [CrossRef]
. Labban, R.S.M.; Alfawaz, H.; Almnaizel, A.T.; Hassan, W.M.; Bhat, R.S.; Moubayed, N.M.; Bjørklund, G.; El-Ansary, A. High-fat diet-induced obesity and impairment of brain neurotransmitter pool. Transl. Neurosci. 2020, 11, 147–160. [Google Scholar] [CrossRef]
. Boswell, R.G.; Potenza, M.N.; Grilo, C.M. The Neurobiology of Binge-eating Disorder Compared with Obesity: Implications for Differential Therapeutics. Clin. Ther. 2021, 43, 50–69. [Google Scholar] [CrossRef]
. Gómez-Apo, E.; Mondragón-Maya, A.; Ferrari-Díaz, M.; Silva-Pereyra, J. Structural Brain Changes Associated with Overweight and Obesity. J. Obes. 2021, 2021, 6613385. [Google Scholar] [CrossRef]
. McCabe, D.P.; Roediger, H.L.; McDaniel, M.A.; Balota, D.A.; Hambrick, D.Z. The relationship between working memory capacity and executive functioning: Evidence for a common executive attention construct. Neuropsychology 2010, 24, 222–243. [Google Scholar] [CrossRef] [PubMed]
. Higgs, S.; Spetter, M.S.; Thomas, J.M.; Rotshtein, P.; Lee, M.; Hallschmid, M.; Dourish, C.T. Interactions between metabolic, reward and cognitive processes in appetite control: Implications for novel weight management therapies. J. Psychopharmacol. 2017, 31, 1460–1474. [Google Scholar] [CrossRef] [PubMed]
. Davidson, T.L.; Jones, S.; Roy, M.; Stevenson, R.J. The Cognitive Control of Eating and Body Weight: It’s More Than What You “Think”. Front. Psychol. 2019, 10, 62. [Google Scholar] [CrossRef] [PubMed]
. Favieri, F.; Forte, G.; Casagrande, M. The Executive Functions in Overweight and Obesity: A Systematic Review of Neuropsychological Cross-Sectional and Longitudinal Studies. Front. Psychol. 2019, 10, 2126. [Google Scholar] [CrossRef] [PubMed]
. Garza, J.C.; Guo, M.; Zhang, W.; Lu, X.Y. Leptin increases adult hippocampal neurogenesis in vivo and in vitro. J. Biol. Chem. 2008, 283, 18238–18247. [Google Scholar] [CrossRef]
. Irving, A.J.; Harvey, J. Leptin regulation of hippocampal synaptic function in health and disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2013, 369, 20130155. [Google Scholar] [CrossRef]
. Forny-Germano, L.; De Felice, F.G.; Vieira, M.N.D.N. The Role of Leptin and Adiponectin in Obesity-Associated Cognitive Decline and Alzheimer’s Disease. Front. Neurosci. 2019, 12, 1027. [Google Scholar] [CrossRef]
. DeFronzo, R.A.; Ferrannini, E.; Groop, L.; Henry, R.R.; Herman, W.H.; Holst, J.J.; Hu, F.B.; Kahn, C.R.; Raz, I.; Shulman, G.I.; et al. Type 2 diabetes mellitus. Nat. Rev. Dis. Primers 2015, 1, 15019. [Google Scholar] [CrossRef]
. Müller, T.D.; Blüher, M.; Tschöp, M.H.; DiMarchi, R.D. Anti-obesity drug discovery: Advances and challenges. Nat. Rev. Drug Discov. 2022, 21, 201–223. [Google Scholar] [CrossRef] [PubMed]
. Moghazy, H.M.; Abdelhaliem, N.G.; Mohammed, S.A.; Hassan, A.; Abdelrahman, A. Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet-streptozocin rat model. Pflug. Arch. 2024, 476, 779–795. [Google Scholar] [CrossRef] [PubMed]
Patrick, S.; Corrigan, R.; Grizzanti, J.; Mey, M.; Blair, J.; Pallas, M.; Camins, A.; Lee, H.G.; Casadesus, G. Neuroprotective Effects of the Amylin Analog, Pramlintide, on Alzheimer’s Disease Are Associated with Oxidative Stress Regulation Mechanisms. J. Alzheimer’s Dis. 2019, 69, 157–168. [Google Scholar] [CrossRef]
.Qiu, W.Q.; Zhu, H. Amylin and its analogs: A friend or foe for the treatment of Alzheimer’s disease? Front. Aging Neurosci. 2014, 6, 186. [Google Scholar] [CrossRef]
. D’Ascanio, A.M.; Mullally, J.A.; Frishman, W.H. Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity. Cardiol. Rev. 2024, 32, 83–90. [Google Scholar] [CrossRef] [PubMed]
. Enebo, L.B.; Berthelsen, K.K.; Kankam, M.; Lund, M.T.; Rubino, D.M.; Satylganova, A.; Lau, D.C.W. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: A randomised, controlled, phase 1b trial. Lancet 2021, 397, 1736–1748. [Google Scholar] [CrossRef]
. Gadde, K.M.; Allison, D.B. Long-acting amylin analogue for weight reduction. Lancet 2021, 398, 2132–2134. [Google Scholar] [CrossRef]
. Lau, D.C.W.; Erichsen, L.; Francisco, A.M.; Satylganova, A.; le Roux, C.W.; McGowan, B.; Pedersen, S.D.; Pietiläinen, K.H.; Rubino, D.; Batterham, R.L. Once-weekly cagrilintide for weight management in people with overweight and obesity: A multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. Lancet 2021, 398, 2160–2172. [Google Scholar] [CrossRef]
Becerril, S.; Frühbeck, G. Cagrilintide plus semaglutide for obesity management. Lancet 2021, 397, 1687–1689. [Google Scholar] [CrossRef]
. Wu, T.; Gao, X.; Chen, M.; van Dam, R.M. Long-term effectiveness of diet-plus-exercise interventions vs. diet-only interventions for weight loss: A meta-analysis. Obes. Rev. 2009, 10, 313–323. [Google Scholar] [CrossRef]
. Miller, C.T.; Fraser, S.F.; Levinger, I.; Straznicky, N.E.; Dixon, J.B.; Reynolds, J.; Selig, S.E. The effects of exercise training in addition to energy restriction on functional capacities and body composition in obese adults during weight loss: A systematic review. PLoS ONE 2013, 8, e81692. [Google Scholar] [CrossRef]
. Khalafi, M.; Azali Alamdari, K.; Symonds, M.E.; Rohani, H.; Sakhaei, M.H. A comparison of the impact of exercise training with dietary intervention versus dietary intervention alone on insulin resistance and glucose regulation in individual with overweight or obesity: A systemic review and meta-analysis. Crit. Rev. Food Sci. Nutr. 2023, 63, 9349–9363. [Google Scholar] [CrossRef] [PubMed]
. Lecoultre, V.; Ravussin, E.; Redman, L.M. The fall in leptin concentration is a major determinant of the metabolic adaptation induced by caloric restriction independently of the changes in leptin circadian rhythms. J. Clin. Endocrinol. Metab. 2011, 96, E1512–E1516. [Google Scholar] [CrossRef] [PubMed]
. Rodrigues, K.C.D.C.; Pereira, R.M.; de Campos, T.D.P.; de Moura, R.F.; da Silva, A.S.R.; Cintra, D.E.; Ropelle, E.R.; Pauli, J.R.; de Araújo, M.B.; de Moura, L.P. The Role of Physical Exercise to Improve the Browning of White Adipose Tissue via POMC Neurons. Front. Cell. Neurosci. 2018, 12, 88. [Google Scholar] [CrossRef] [PubMed]
. Li, C.; Meng, F.; Lei, Y.; Liu, J.; Liu, J.; Zhang, J.; Liu, F.; Liu, C.; Guo, M.; Lu, X.Y. Leptin regulates exon-specific transcription of the Bdnf gene via epigenetic modifications mediated by an AKT/p300 HAT cascade. Mol. Psychiatry 2021, 26, 3701–3722. [Google Scholar] [CrossRef]
. Yu, W.H.; Kimura, M.; Walczewska, A.; Karanth, S.; McCann, S.M. Role of leptin in hypothalamic-pituitary function. Proc. Natl. Acad. Sci. USA 1997, 94, 1023–1028. [Google Scholar] [CrossRef] [PubMed]
Ahima, R.S.; Prabakaran, D.; Mantzoros, C.; Qu, D.; Lowell, B.; Maratos-Flier, E.; Flier, J.S. Role of leptin in the neuroendocrine response to fasting. Nature 1996, 382, 250–252. [Google Scholar] [CrossRef]
. Harvey, J. Novel Leptin-Based Therapeutic Strategies to Limit Synaptic Dysfunction in Alzheimer’s Disease. Int. J. Mol. Sci. 2024, 25, 7352. [Google Scholar] [CrossRef]
. Horie, N.C.; Serrao, V.T.; Simon, S.S.; Gascon, M.R.; Dos Santos, A.X.; Zambone, M.A.; Del Bigio de Freitas, M.M.; Cunha-Neto, E.; Marques, E.L.; Halpern, A.; et al. Cognitive Effects of Intentional Weight Loss in Elderly Obese Individuals With Mild Cognitive Impairment. J. Clin. Endocrinol. Metab. 2016, 101, 1104–1112. [Google Scholar] [CrossRef]
. Wittekind, D.A.; Kratzsch, J.; Mergl, R.; Baber, R.; Wirkner, K.; Schroeter, M.L.; Witte, A.V.; Villringer, A.; Kluge, M. Leptin, but not ghrelin, is associated with food addiction scores in a population-based subject sample. Front. Psychiatry 2023, 14, 1200021. [Google Scholar]
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
